Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Inhaled Insulin vs Rosiglitazone in Type 2 Diabetes
NCT00343980Phase 3Terminated
- Sponsor
- Novo Nordisk
- Start
- Oct 2006
- Primary completion
- Mar 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 7
01
Overview
A Phase 3 trial of regular human insulin in type 2 diabetes mellitus (T2DM), sponsored by Novo Nordisk. Started Oct 2006; status: terminated.
02
Drugs
regular human insulin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00343980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00343980.